- Home
- BLBD vs HCM Comparison
BLBD vs HCM Comparison
Compare BLBD & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLBD | HCM |
|---|---|---|
| Founded | 1927 | 2000 |
| Country | United States | Hong Kong |
| Employees | N/A | 1811 |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.6B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | BLBD | HCM |
|---|---|---|
| Price | $62.81 | $13.43 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 6 | 1 |
| Target Price | ★ $68.00 | $13.75 |
| AVG Volume (30 Days) | ★ 289.9K | 35.3K |
| Earning Date | 05-06-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.78 | N/A |
| EPS | ★ 0.94 | N/A |
| Revenue | ★ $1,480,099,000.00 | N/A |
| Revenue This Year | $5.87 | $20.60 |
| Revenue Next Year | $6.83 | $15.62 |
| P/E Ratio | $68.46 | ★ $5.49 |
| Revenue Growth | ★ 9.87 | N/A |
| 52 Week Low | $34.19 | $13.06 |
| 52 Week High | $66.13 | $19.50 |
Technical Indicators
Market Signals| Indicator | BLBD | HCM |
|---|---|---|
| Relative Strength Index (RSI) | 56.55 | 32.61 |
| Support Level | $53.30 | $13.08 |
| Resistance Level | $65.47 | $15.59 |
| Average True Range (ATR) | 2.13 | 0.45 |
| MACD | 0.03 | -0.24 |
| Stochastic Oscillator | 57.20 | 5.24 |
Price Performance
Historical ComparisonAbout BLBD Blue Bird Corporation
Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.